Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Completed NA INTERVENTIONAL NCT02324881

Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

This pilot clinical trial studies a pain management smartphone application for monitoring pain in patients with locally advanced head and neck cancer who are undergoing radiation therapy. The study is also open to patients with esophageal or lung cancer. A smartphone application may allow patients to assess their symptoms in a manner that is closer to real-time than having to recall pain episodes during once weekly on-treatment visits with a health care provider. This real-time monitoring may improve the timing and efficacy of interventions leading to better pain-control and quality of life.

Detailed Description

PRIMARY OBJECTIVES: I. Obtain consumer input to determine the optimal way to address and monitor the patient's symptoms. II. Train patients to use the pain management smartphone application (PMSA) and determine the compliance characteristics and the number of additional on-treatment visits (OTVs) prompted by usage of the application. OUTLINE: Selected patients are interviewed for input that will help guide the wording of questions of the PMSA. All patients/caregivers are then instructed to download the PMSA and are demonstrated how to properly use the application. Beginning on the first day of radiation therapy (day 1), patients are instructed to use the PMSA for the duration of their radiation therapy (up to day 50), although the timing may change based on the availability of the app.

Interventions

Name: Telephone-Based Intervention
Type: BEHAVIORAL
Description: Use PSMA
Name: Questionnaire Administration
Type: OTHER
Description: Ancillary studies

Primary Outcomes

Measure: Compliance characteristics of patients' use of the pain management smartphone application
TimeFrame: Up to day 50
Description: Summaries of feasibility will be generated using rates (percentages). Descriptive statistics will be used to summarize patient ratings of satisfaction regarding the PMSA, instruction, usage, and future recommendation.

Trial Information

NCT ID

NCT02324881

Status

Completed

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

Vanderbilt-Ingram Cancer Center

Last Updated

December 15, 2025